Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.84	3.69	6.58	25.91	27.33	15.23
Short-Term Investments	-	-	-	-	-	1.17
Cash & Short-Term Investments	2.84	3.69	6.58	25.91	27.33	16.4
Cash Growth	-54.64%	-43.89%	-74.61%	-5.19%	66.63%	-45.83%
Accounts Receivable	21.21	11.34	13.45	14.17	21.42	20.35
Other Receivables	0.23	1.67	2.21	1.54	3.18	2.04
Receivables	21.44	13.01	15.66	15.71	24.6	22.39
Inventory	21.8	19.93	22.5	29.12	30.22	32.02
Prepaid Expenses	-	2.04	1.93	1.95	1.16	0.58
Other Current Assets	-	0.37	-	-	-	-
Total Current Assets	46.08	39.04	46.67	72.69	83.3	71.39
Property, Plant & Equipment	3.77	1.89	5.68	5.92	8.55	9.29
Goodwill	-	-	12.54	12.54	12.59	12.59
Other Intangible Assets	46.67	1.17	5.72	5.77	7.83	8.29
Long-Term Accounts Receivable	-	0.04	0.08	0.15	0.29	0.4
Long-Term Deferred Tax Assets	0.69	1.98	4.22	4.1	4.19	6.25
Long-Term Deferred Charges	-	15.1	17.01	17.68	13.44	22.78
Other Long-Term Assets	0.23	0.22	0.18	0.06	0.21	0.08
Total Assets	97.45	59.44	92.1	118.9	130.4	131.07
Accounts Payable	25.31	3.89	6.21	6.76	7.1	7.83
Accrued Expenses	-	8.07	9.06	8.12	9.69	7.52
Short-Term Debt	-	-	-	0.03	2.91	-
Current Portion of Long-Term Debt	0.21	0.21	0.21	83.31	-	-
Current Portion of Leases	2.15	1.69	1.68	1.98	2.15	2.4
Current Income Taxes Payable	0.33	0.28	0.03	0.02	0.15	0.05
Current Unearned Revenue	-	0.05	0.11	0.21	4.45	0.29
Other Current Liabilities	0.05	0.85	0.05	0.05	0.61	1.36
Total Current Liabilities	28.05	15.04	17.34	100.49	27.06	19.45
Long-Term Debt	81.62	54.65	58.05	-	82.7	82.02
Long-Term Leases	9.73	10.87	12.27	13.87	16.59	17.75
Long-Term Deferred Tax Liabilities	1.99	2.3	5.06	4.86	4.91	7.14
Other Long-Term Liabilities	2.39	0.53	1.57	-	1.37	0
Total Liabilities	123.79	83.38	94.28	119.21	132.62	126.36
Common Stock	2.38	1.97	1.96	1.21	1.21	1.21
Additional Paid-In Capital	57.52	46.62	46.46	16.19	16.19	16.19
Retained Earnings	-62.3	-48.64	-26.7	12.56	10.57	16.15
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92	-24.92
Comprehensive Income & Other	0.98	1.03	1.02	-5.36	-5.27	-3.91
Shareholders' Equity	-26.34	-23.95	-2.18	-0.32	-2.22	4.71
Total Liabilities & Equity	97.45	59.44	92.1	118.9	130.4	131.07
Total Debt	93.72	67.43	72.2	99.19	104.34	102.17
Net Cash (Debt)	-90.88	-63.74	-65.62	-73.28	-77.01	-85.77
Net Cash Per Share	-9.99	-8.33	-9.73	-17.53	-18.42	-20.52
Filing Date Shares Outstanding	10.39	9.47	7.64	5.38	4.18	4.18
Total Common Shares Outstanding	10.39	7.67	7.62	4.18	4.18	4.18
Working Capital	18.03	24.01	29.33	-27.8	56.24	51.94
Book Value Per Share	-2.54	-3.12	-0.29	-0.08	-0.53	1.13
Tangible Book Value	-73.02	-25.12	-20.44	-18.62	-22.64	-16.16
Tangible Book Value Per Share	-7.03	-3.28	-2.68	-4.45	-5.41	-3.87
Land	-	24.27	24.68	24.33	24.29	24.27
Machinery	-	39.04	38.22	36.54	38.15	42.97
Leasehold Improvements	-	2.76	2.7	2.59	2.67	3.01

Source: S&P Capital IQ. Standard template. Financial Sources.